Hudson Bay Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,636
| Closed | -$61.6K | – | 623 |
|
|
2023
Q4 | $61.6K | Hold |
13,636
| – | – | ﹤0.01% | 508 |
|
|
2023
Q3 | $48.8K | Hold |
13,636
| – | – | ﹤0.01% | 562 |
|
|
2023
Q2 | $50.3K | Sell |
13,636
-592,847
| -98% | -$2.19M | ﹤0.01% | 604 |
|
|
2023
Q1 | $2.01M | Sell |
606,483
-1,056,299
| -64% | -$3.5M | 0.02% | 486 |
|
|
2022
Q4 | $6.45M | Sell |
1,662,782
-354,483
| -18% | -$1.38M | 0.07% | 258 |
|
|
2022
Q3 | $4.9M | Sell |
2,017,265
-133,307
| -6% | -$324K | 0.04% | 403 |
|
|
2022
Q2 | $4.26M | Sell |
2,150,572
-150,000
| -7% | -$297K | 0.03% | 462 |
|
|
2022
Q1 | $4.21M | Buy |
+2,300,572
| New | +$4.21M | 0.06% | 419 |
|
|
2020
Q4 | – | Sell |
-110,000
| Closed | -$263K | – | 568 |
|
|
2020
Q3 | $263K | Sell |
110,000
-135,000
| -55% | -$323K | ﹤0.01% | 461 |
|
|
2020
Q2 | $717K | Buy |
+245,000
| New | +$717K | 0.01% | 384 |
|